Jeffrey B Kindler

Director · 3 filings · Latest: Jun 10, 2026

PRECIGEN, INC.

Praxis Precision Medicines, Inc.

Terns Pharmaceuticals, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PRAX	Jeffrey B Kindler	Director	Jun 10, 2026	Grant/Award	$0.00	1,371	—	2,537	Jun 12 5:23 PM
PGEN	Jeffrey B Kindler	Director	Mar 13, 2026	Option Exercise	—	71,839	—	202,100	Mar 16 5:07 PM